We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGCO icon
1651
AGCO
AGCO
$7.2B
$61K ﹤0.01%
809
-2,145
-73% -$158K
BNED icon
1652
Barnes & Noble Education
BNED
$443M
$61K ﹤0.01%
196
-25
-11% -$8.75K
BOTZ icon
1653
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.51B
$61K ﹤0.01%
+3,066
New +$59.9K
BSM icon
1654
Black Stone Minerals
BSM
$3B
$61K ﹤0.01%
+4,297
New +$63K
ERIE icon
1655
Erie Indemnity
ERIE
$13.2B
$61K ﹤0.01%
+329
New +$74.7K
ESLT icon
1656
Elbit Systems
ESLT
$40.3B
$61K ﹤0.01%
370
+18
+5% +$2.84K
CBIO
1657
Crescent Biopharma
CBIO
$626M
$61K ﹤0.01%
140
+138
+6,900% +$88.8K
ITOT icon
1658
iShares Core S&P Total US Stock Market ETF
ITOT
$97.8B
$61K ﹤0.01%
908
+190
+26% +$12.7K
JQC icon
1659
Nuveen Credit Strategies Income Fund
JQC
$711M
$61K ﹤0.01%
+8,097
New +$61.7K
KMPR icon
1660
Kemper
KMPR
$1.68B
$61K ﹤0.01%
789
-31,950
-98% -$2.55M
MANH icon
1661
Manhattan Associates
MANH
$11.4B
$61K ﹤0.01%
751
-2,852
-79% -$229K
PI icon
1662
Impinj
PI
$5.6B
$61K ﹤0.01%
+1,977
New +$69K
TTC icon
1663
Toro Company
TTC
$9.49B
$61K ﹤0.01%
833
-6,086
-88% -$435K
CBAY
1664
DELISTED
Cymabay Therapeutics
CBAY
$61K ﹤0.01%
+11,950
New +$72.3K
HI
1665
DELISTED
Hillenbrand
HI
$60K ﹤0.01%
1,959
-1,003
-34% -$31.8K
INDA icon
1666
iShares MSCI India ETF
INDA
$6.63B
$60K ﹤0.01%
1,773
-7,046
-80% -$233K
ABB
1667
DELISTED
ABB Ltd
ABB
$60K ﹤0.01%
3,086
+1,086
+54% +$20.7K
DZSI
1668
DELISTED
DZS Inc. Common Stock
DZSI
$60K ﹤0.01%
6,594
+4,659
+241% +$51K
ABUS icon
1669
Arbutus Biopharma
ABUS
$915M
$59K ﹤0.01%
38,789
+34,005
+711% +$58.6K
ADNT icon
1670
Adient
ADNT
$1.5B
$59K ﹤0.01%
2,553
+1,223
+92% +$27.9K
BCC icon
1671
Boise Cascade
BCC
$3.02B
$59K ﹤0.01%
1,820
+260
+17% +$7.62K
ENSG icon
1672
The Ensign Group
ENSG
$10.7B
$59K ﹤0.01%
1,336
+467
+54% +$23.1K
FCNCA icon
1673
First Citizens BancShares
FCNCA
$25.3B
$59K ﹤0.01%
+125
New +$56.9K
JBSS icon
1674
John B. Sanfilippo & Son
JBSS
$972M
$59K ﹤0.01%
611
+536
+715% +$46.6K
NWN icon
1675
Northwest Natural Holdings
NWN
$2.12B
$59K ﹤0.01%
+825
New +$58.5K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.